Elevance Health is trading lower today, tracking a broader downward trend among its peers as Centene and Molina Healthcare are also seeing similar declines. While the company recently received favorable indicative credit ratings from AM Best for its new shelf registration, this news has not been enough to decouple the stock from the wider weakness in the managed care sector. Despite recent positive analysis highlighting the company's superior valuation metrics—including a forward P/E ratio of 14.97 and a PEG ratio of 2.08—the stock remains under mild pressure alongside its industry counterparts.